Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors

The aim of the present study was to assess the effect of Endostar and temozolomide or dacarbazine plus 5-fluorouracil (5-FU) in patients with advanced pancreatic neuroendocrine tumors (pNETs). Phase II study of 14 patients with locally advanced or metastatic well-differentiated pNETs treated between...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yue-Juan, Meng, Chang-Ting, Ying, Hong-Yan, Zhou, Jian-Feng, Yan, Xiao-Yan, Gao, Xin, Zhou, Na, Bai, Chun-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250533/
https://www.ncbi.nlm.nih.gov/pubmed/30407280
http://dx.doi.org/10.1097/MD.0000000000012750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250533/
https://www.ncbi.nlm.nih.gov/pubmed/30407280
http://dx.doi.org/10.1097/MD.0000000000012750

Ejemplares similares